SCHEMBL21137102

SCHEMBL21137102

Cc1ccc2[nH]ncc2c1-c1cc2ncc(N(C)CCN(C)C)c(N3CCN(C(=O)OC(C)(C)C)CC3)c2cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KRAS P01116 17/20 0.51
SUV39H2 Q9H5I1 2/20 0.37
HAVCR2 Q8TDQ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21099346 0.80 KRAS (0.55) KRAS
SCHEMBL29765795 0.79 KRAS (0.54) KRASHAVCR2
SCHEMBL17030835 0.79 KRAS (0.54) KRASHAVCR2
SCHEMBL21099360 0.75 KRAS (0.79) KRAS
SCHEMBL21099996 0.75 KRAS (0.79) KRAS
SCHEMBL16647033 0.73 KRAS (0.48) KRASSUV39H2HAVCR2
SCHEMBL19412040 0.72 KRAS (0.73) KRAS
SCHEMBL29765698 0.72 KRAS (0.69) KRAS
SCHEMBL16646907 0.72 KRAS (0.69) KRAS
SCHEMBL16647073 0.71 KRAS (0.68) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed